Entries by Peggy Bickerton

Otsuka Signs Statement of Support for Women’s Empowerment Principles

19 January 2018 in , /by

January　19, 2018 Otsuka Signs Statement of Support for Women’s Empowerment Principles Astex Pharmaceuticals (“Astex”), an indirect subsidiary of Otsuka Holdings Co., Ltd., announces that the latter has signed the CEO Statement of Support for the Women’s Empowerment Principles (WEPs), a set of Principles focusing on corporate action to promote gender equality and women’s empowerment in […]

Astex Pharmaceuticals Celebrates as Cancer Drug Receives Marketing Approval in Europe

24 August 2017 in , /by

Further Milestone Payment Under Novartis Collaboration as Kisqali® (ribociclib) Receives Approval in Europe as a First-Line Treatment for HR+/HER2- locally Advanced or Metastatic Breast Cancer with an Aromatase Inhibitor – Kisqali was discovered as part of a strategic research collaboration under which Astex and Novartis Institutes for BioMedical Research (NIBR) scientists jointly developed and optimised […]

Cambridge-based Astex Pharmaceuticals Celebrates as Cancer Drug Receives US Marketing Approval

13 March 2017 in , /by

Further Milestone Payment Under Novartis Collaboration as Kisqali® (ribociclib) Receives FDA approval as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer with an aromatase inhibitor Novartis drug Kisqali® (ribociclib, LEE011) receives marketing approval by the US FDA as a first-line drug for HR+/HER2- advanced breast cancer in combination with an aromatase inhibitor Astex’s scientific expertise […]